Summary: Analysts are bullish on Adverum Biotechnologies (ADVM), Gilead Sciences (GILD), and CVRx (CVRX) in the Healthcare sector.
Full articleSummary: CVRx Inc (NASDAQ:CVRX) was downgraded by William Blair from Outperform to Market Perform due to first-quarter sales falling short of expectations, leading to lower revenue guidance and internal salesforce issues impacting performance.
Full article